Heidi Larson – The Conversation

South Africa’s president, Cyril Ramaphosa, receives the COVID-19 vaccine. Leaders have publicly taken the vaccine to encourage others to do the same. Photo by Brenton Geach/Gallo Images via Getty Images

May 5, 2021

Vaccinating Africa against COVID‑19: riding a roller coaster of poor information

Heidi Larson, London School of Hygiene & Tropical Medicine and Raji Tajudeen

Recent uncertainty over blood clots and vaccine expiration dates have taken a toll on public confidence.

The increasingly well-coordinated global anti-vaccine movement has repurposed itself to challenge the very reality of COVID-19. Hasan Esen/Anadolu Agency via Getty Images

October 28, 2020

COVID‑19: A global survey shows worrying signs of vaccine hesitancy

Scott C. Ratzan, CUNY Graduate Center; Agnes Binagwaho, University of Global Health Equity; Heidi Larson, London School of Hygiene & Tropical Medicine; Jeffrey V Lazarus, Barcelona Institute for Global Health (ISGlobal); Kenneth Rabin, CUNY Graduate Center, and Lawrence O. Gostin, Georgetown University

A safe, effective COVID-19 vaccine is expected to be developed in record time and may be approved for production, distribution and acceptance some time in 2021.

Mind the gap: Japanese school girls were covered but not the boys. Flickr/thecrypt

July 11, 2013

Vaccination gaps led to rubella outbreaks in Japan and Poland

Heidi Larson, London School of Hygiene & Tropical Medicine

Recent rubella outbreaks in Japan and Poland are the clearest evidence possible that herd immunity matters. There are many reasons why people don’t get vaccinated for totally preventable diseases such…

Contact Heidi for